Q4 2024 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2025-02-14 · accession 0001920938-25-000002
$3.37B
Reported value
73
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131MAB5 | GH 0 11/15/27 | GUARDANT HEALTH INC | $226.0M | 6.70% | 268,252,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $148.1M | 4.39% | 140,838,000 | Common | SOLE |
| 67011XAB9 | NVCR 0 11/01/25 | NOVOCURE LTD | $134.5M | 3.99% | 140,834,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $123.1M | 3.65% | 901,790 | Common | SOLE |
| 759916AD1 | RGEN 1 12/15/28 | REPLIGEN CORP | $114.8M | 3.40% | 112,000,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $114.2M | 3.39% | 2,913,964 | Common | SOLE |
| 670704AJ4 | GMED 0.375 03/15/25 | NUVASIVE INC | $113.2M | 3.36% | 114,206,000 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $98.3M | 2.91% | 116,381,000 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $96.9M | 2.87% | 2,977,951 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $94.2M | 2.79% | 3,283,317 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $87.0M | 2.58% | 2,847,931 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $85.2M | 2.53% | 92,740,000 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $78.2M | 2.32% | 375,179 | Common | SOLE |
| 252131AM9 | DXCM 0.375 05/15/28 | DEXCOM INC | $74.4M | 2.21% | 82,700,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $69.8M | 2.07% | 1,540,362 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $68.3M | 2.02% | 3,452,447 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $67.0M | 1.99% | 2,098,866 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $63.6M | 1.89% | 705,391 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $62.3M | 1.85% | 2,332,196 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $61.8M | 1.83% | 4,873,853 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $60.0M | 1.78% | 2,578,404 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $59.5M | 1.77% | 1,479,666 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $57.5M | 1.70% | 922,100 | Common | SOLE |
| 02081GAB8 | ATEC 0.75 08/01/26 | ALPHATEC HLDGS INC | $55.1M | 1.63% | 58,217,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $54.4M | 1.61% | 293,410 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $49.7M | 1.47% | 80,766 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $46.7M | 1.38% | 89,754 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $46.0M | 1.36% | 53,594,000 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $45.5M | 1.35% | 8,353,287 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $44.4M | 1.32% | 364,900 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $43.7M | 1.29% | 183,828 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $43.3M | 1.28% | 288,876 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $43.2M | 1.28% | 4,105,726 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $40.9M | 1.21% | 283,823 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $39.6M | 1.17% | 3,834,809 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $39.3M | 1.17% | 75,300 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $39.1M | 1.16% | 4,256,490 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $35.3M | 1.05% | 309,865 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $34.9M | 1.03% | 2,000,659 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $31.4M | 0.93% | 200,500 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $30.4M | 0.90% | 907,039 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $30.0M | 0.89% | 1,894,439 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $27.1M | 0.80% | 1,147,676 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $26.3M | 0.78% | 1,206,589 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $25.7M | 0.76% | 1,107,770 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $24.9M | 0.74% | 3,503,965 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $24.8M | 0.74% | 7,006,315 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $24.1M | 0.71% | 5,440,277 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $20.7M | 0.61% | 353,200 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $19.8M | 0.59% | 353,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $18.9M | 0.56% | 241,235 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $18.2M | 0.54% | 222,424 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $17.9M | 0.53% | 1,477,102 | Common | SOLE |
| 252131AK3 | DXCM 0.25 11/15/25 | DEXCOM INC | $17.9M | 0.53% | 18,500,000 | Common | SOLE |
| 03209RAB9 | AMPH 2 03/15/29 | AMPHASTAR PHARMACEUTICALS IN | $16.3M | 0.48% | 17,400,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $16.0M | 0.48% | 681,182 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $15.3M | 0.45% | 714,658 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $14.3M | 0.42% | 1,176,173 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $14.1M | 0.42% | 615,531 | Common | SOLE |
| 137404109 | CADL | CANDEL THERAPEUTICS INC | $13.9M | 0.41% | 1,600,000 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $11.9M | 0.35% | 802,100 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $11.6M | 0.34% | 884,306 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $6.8M | 0.20% | 1,225,448 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $6.3M | 0.19% | 1,698,768 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $6.2M | 0.18% | 2,472,806 | Common | SOLE |
| 15678C102 | CBLL | CERIBELL INC | $5.4M | 0.16% | 210,000 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $5.1M | 0.15% | 752,541 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $3.8M | 0.11% | 1,440,499 | Common | SOLE |
| 232109AG3 | — | CUTERA INC | $2.6M | 0.08% | 29,000,000 | Common | SOLE |
| 83086J200 | SKYE | SKYE BIOSCIENCE INC | $2.3M | 0.07% | 825,732 | Common | SOLE |
| 232109AD0 | — | CUTERA INC | $2.3M | 0.07% | 25,240,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $776,207 | 0.02% | 20,109 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $653,582 | 0.02% | 34,094 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.